CRISPR Therapeutics AG banner

CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 52.02 USD -4% Market Closed
Market Cap: $5B

Intrinsic Value

The intrinsic value for CRISPR Therapeutics AG (CRSP) under the Base Case is 6.31 USD. Compared with the current market price of 52.02 USD, the stock appears Overvalued by 88% .

CRSP Intrinsic Value
6.31 USD
Overvaluation 88%
Intrinsic Value
Price $52.02
Bear Case
Base Case
Bull Case
Monitor CRSP
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $5.05
Get notified when the price drops into your buy zone
Current Price $52.02
Intrinsic Value $6.31
Margin of Safety 20% $5.05
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about CRSP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CRSP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CRISPR Therapeutics AG.

Explain Valuation
Alternatives to CRSP

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CRSP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CRSP stock?

The intrinsic value for CRISPR Therapeutics AG (CRSP) under the Base Case is 6.31 USD.

Is CRSP stock undervalued or overvalued?

Compared with the current market price of 52.02 USD, the stock appears Overvalued by 88% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett